We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVEE
3001
DELISTED
NV5 Global
NVEE
$23K ﹤0.01%
700
-9,228
-93% -$321K
OLP
3002
One Liberty Properties
OLP
$531M
$23K ﹤0.01%
1,048
+6
+0.6% +$137
RCEL icon
3003
Avita Medical
RCEL
$241M
$23K ﹤0.01%
3,464
+1,845
+114% +$11.1K
REI icon
3004
Ring Energy
REI
$357M
$23K ﹤0.01%
9,329
-5,915
-39% -$16.2K
SFST icon
3005
Southern First Bancshares
SFST
$613M
$23K ﹤0.01%
494
-3
-0.6% -$136
SMTI icon
3006
Sanara MedTech
SMTI
$314M
$23K ﹤0.01%
507
+153
+43% +$5.27K
TIGR
3007
UP Fintech Holding
TIGR
$820M
$23K ﹤0.01%
6,487
+5,695
+719% +$24.6K
TNGX icon
3008
Tango Therapeutics
TNGX
$4.23B
$23K ﹤0.01%
3,222
-18
-0.6% -$127
TRC icon
3009
Tejon Ranch
TRC
$442M
$23K ﹤0.01%
1,195
-590
-33% -$10.3K
UEC icon
3010
Uranium Energy
UEC
$5.66B
$23K ﹤0.01%
6,035
-18,830
-76% -$71.5K
VABK icon
3011
Virginia National Bankshares
VABK
$254M
$23K ﹤0.01%
+622
New +$21.3K
VBTX
3012
DELISTED
Veritex Holdings
VBTX
$23K ﹤0.01%
837
-10,947
-93% -$325K
VIGL
3013
DELISTED
Vigil Neuroscience
VIGL
$23K ﹤0.01%
+1,832
New +$22.5K
WBND
3014
DELISTED
Western Asset Total Return ETF
WBND
$23K ﹤0.01%
1,145
+902
+371% +$17.8K
WIT icon
3015
Wipro
WIT
$19.2B
$23K ﹤0.01%
9,938
-31,504
-76% -$75.3K
QTTB icon
3016
Q32 Bio
QTTB
$455M
$23K ﹤0.01%
997
+658
+194% +$17.5K
OMGA
3017
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$23K ﹤0.01%
3,952
-5,011
-56% -$28.1K
AGR
3018
DELISTED
Avangrid, Inc.
AGR
$23K ﹤0.01%
531
-515
-49% -$21.3K
ORGS
3019
DELISTED
Orgenesis Inc. Common Stock
ORGS
$23K ﹤0.01%
1,179
+210
+22% +$3.58K
SPLK
3020
DELISTED
Splunk Inc
SPLK
$23K ﹤0.01%
269
-35,638
-99% -$2.88M
ALYA
3021
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
$23K ﹤0.01%
15,780
+8,135
+106% +$14K
NVTA
3022
DELISTED
Invitae Corporation
NVTA
$23K ﹤0.01%
12,489
-69,681
-85% -$170K
VRTV
3023
DELISTED
VERITIV CORPORATION
VRTV
$23K ﹤0.01%
190
-1,108
-85% -$134K
GHL
3024
DELISTED
Greenhill & Co., Inc.
GHL
$23K ﹤0.01%
2,283
+2,069
+967% +$17.9K
BBIG
3025
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$23K ﹤0.01%
2,431
+1,776
+271% +$27.3K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.